Renovos is a company that provides orthopedic regenerative medicine solutions. It develops a synthetic nanoclay gel technology platform named Renovite for tissue healing. Renovos' offering also includes primary mesenchymal stem cells for research, sourced from elderly and orthopedic patient cohorts, as well as research services for screening and testing of biomaterials and compounds for biocompatibility, toxicology, angiogenesis, and bone/cartilage regeneration.